Cosmetics and pharmaceuticals: active ingredients with dual benefits

Appearance and health overlap, and so do the products aimed at each. Many of the actives in a skincare routine also appear in medicines: sometimes the same molecule, at a different concentration, under a different regulatory pathway. It is worth understanding what separates the categories.

Cosmetic, drug, and the line between

The boundary is drawn by claim and intended use, not by the ingredient or its purity.

A cosmetic is intended to cleanse, beautify, perfume or alter appearance. A drug is intended to diagnose, treat or prevent disease, or to affect the structure or function of the body. The same formula can be either depending on what is claimed for it, and a product can be both at once: an anti-dandruff shampoo cleans hair (cosmetic) and treats a scalp condition (drug).

One frequently repeated error to correct: the FDA does not regulate cosmetics as foods. Foods and cosmetics are distinct categories under the Federal Food, Drug, and Cosmetic Act, with separate definitions and requirements. Since 2022, MoCRA has also added facility registration, product listing, safety substantiation and adverse-event reporting obligations for cosmetics.

On "pharmaceutical grade"

This phrase does a lot of work in marketing and almost none in regulation. There is no legal definition of "pharmaceutical grade" and no 99.9% purity rule attaching to it. Anyone may print it.

What is meaningful is a pharmacopoeial monograph. USP (United States Pharmacopeia), Ph. Eur. (European Pharmacopoeia) and BP (British Pharmacopoeia) publish specifications for named substances covering identity, assay limits, and specified and unspecified impurities. A material meeting USP or Ph. Eur. specification is a defined, verifiable claim, and the certificate of analysis should reference the monograph. The useful question of a supplier is therefore which monograph, not what grade.

Two related corrections. Cosmetic-grade ingredients are not by definition impure or ineffective; they are made to specifications appropriate to cosmetic use, which for many materials are the same specifications. And pharmaceutical products are not restricted to sale through licensed medical clinics; plenty are sold over the counter in any pharmacy.

What differs between the categories is the evidence and approval requirement. A drug must demonstrate efficacy and safety for its indication before approval. A cosmetic must be safe, and must substantiate its claims, but faces no pre-market efficacy requirement. That is the substantive difference, not purity.

Active ingredients with dual benefits

Vitamin C and vitamin E. Antioxidants in both settings. They neutralise free radicals generated by UV and pollution, and vitamin C is an essential cofactor in collagen synthesis. In medicine they treat deficiency states; in skincare they address photo-ageing and pigmentation. They work well together because one is water-soluble and one oil-soluble, and vitamin C regenerates oxidised vitamin E. See Stamin-C-50 and Stamin-E Acetate.

Alpha hydroxy acids. Glycolic, lactic, mandelic and citric acid. They loosen the bonds between dead corneocytes at the skin surface, improving texture, tone and fine lines. Note that although several occur naturally in fruit and milk, most cosmetic AHAs are synthesised; natural occurrence and commercial origin are separate questions. Consumer cosmetic products generally stay at or below 10%, the level the US Cosmetic Ingredient Review found safe for glycolic and lactic acid at a final pH of 3.5 or above; professional chemical peels use far higher concentrations under supervision, which is the same molecule in a different regulatory category.

Salicylic acid. The clearest illustration of the boundary. At around 2% in a cosmetic cleanser it exfoliates and clears pores. At 17% in a wart remover it is an OTC drug. Same molecule, different concentration, different claim, different pathway.

Retinoids. A continuum from cosmetic to prescription: retinyl esters and retinol are cosmetic ingredients, while tretinoin and isotretinoin are prescription drugs. All act on the same nuclear receptors, with potency, evidence and irritation rising together.

Niacinamide. Vitamin B3, used in medicine for deficiency and in dermatology for several conditions, and in cosmetics for barrier support, sebum regulation, pigmentation and inflammation; it is one of the most versatile actives available. See Stamin-B3-N.

Zinc oxide. A UV filter in sunscreen, and a barrier and antimicrobial agent in nappy-rash creams and calamine. Regulated as an OTC drug ingredient in US sunscreens and as a cosmetic colourant and filter in the EU. See Sunbest-ZnO.

The pattern across all of these is consistent: the molecule is the same, and the concentration, the claim and the regulatory pathway are what change. For how these materials are tested, see how cosmetic actives are tested.